title: Five-year follow-up of a randomized comparison between off-pump and on-pump stable multivessel coronary artery bypass grafting. The MASS III Trial.
abstract: BACKGROUND
  Coronary artery bypass graft surgery with cardiopulmonary bypass is a safe, routine procedure. Nevertheless, significant morbidity remains, mostly because of the body's response to the nonphysiological nature of cardiopulmonary bypass. Few data are available on the effects of off-pump coronary artery bypass graft surgery (OPCAB) on cardiac events and long-term clinical outcomes.
  
  
  RESULTS
  In a single-center randomized trial, 308 patients undergoing coronary artery bypass graft surgery were randomly assigned: 155 to OPCAB and 153 to on-pump CAB (ONCAB). Primary composite end points were death, myocardial infarction, further revascularization (surgery or angioplasty), or stroke. After 5-year follow-up, the primary composite end point was not different between groups (hazard ratio 0.71, 95% CI 0.41 to 1.22; P=0.21). A statistical difference was found between OPCAB and ONCAB groups in the duration of surgery (240±65 versus 300±87.5 minutes; P<0.001), in the length of ICU stay (19.5±17.8 versus 43±17.0 hours; P<0.001), time to extubation (4.6±6.8 versus 9.3±5.7 hours; P<0.001), hospital stay (6±2 versus 9±2 days; P<0.001), higher incidence of atrial fibrillation (35 versus 4% of patients; P<0.001), and blood requirements (31 versus 61% of patients; P<0.001), respectively. The number of grafts per patient was higher in the ONCAB than the OPCAB group (2.97 versus 2.49 grafts/patient; P<0.001).
  
  
  CONCLUSIONS
  No difference was found between groups in the primary composite end point at 5-years follow-up. Although OPCAB surgery was related to a lower number of grafts and higher episodes of atrial fibrillation, it had no significant implications related to long-term outcomes. Clinical Trial Registration-URL: http://www.controlled-trials.com. Unique identifier: ISRCTN66068876.
authors.affiliation: Heart Institute of the University of São Paulo, São Paulo, Brazil. whady.hueb@incor.usp.br
authors.forename: Whady
authors.initials: W
authors.lastname: Hueb
authors.forename: Neuza H
authors.initials: NH
authors.lastname: Lopes
authors.forename: Alexandre C
authors.initials: AC
authors.lastname: Pereira
authors.forename: Alexandre C
authors.initials: AC
authors.lastname: Hueb
authors.forename: Paulo Rogério
authors.initials: PR
authors.lastname: Soares
authors.forename: Desidério
authors.initials: D
authors.lastname: Favarato
authors.forename: Ricardo D'Oliveira
authors.initials: RD
authors.lastname: Vieira
authors.forename: Eduardo Gomes
authors.initials: EG
authors.lastname: Lima
authors.forename: Cibele Larrosa
authors.initials: CL
authors.lastname: Garzillo
authors.forename: Felipe da Silva
authors.initials: Fda S
authors.lastname: Paulitch
authors.forename: Luiz A M
authors.initials: LA
authors.lastname: César
authors.forename: Bernard J
authors.initials: BJ
authors.lastname: Gersh
authors.forename: José A F
authors.initials: JA
authors.lastname: Ramires
mesh_terms: D001281:Atrial Fibrillation / Q000209:etiology / Q000401:mortality; D047549:Coronary Artery Bypass, Off-Pump; D018572:Disease-Free Survival; D005112:Extracorporeal Circulation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000209:etiology / Q000401:mortality; D015996:Survival Rate; D013997:Time Factors